Dr. Reddy’s inks drug pact with Denmark’s 7TM Pharma
March 10th, 2008 - 8:09 pm ICT by admin
-
Mumbai, March 10 (IANS) Dr. Reddy’s Laboratories Ltd, one of India’s leading pharmaceutical companies, has signed an agreement with Denmark-based 7TM Pharma for developing medicines in the area of metabolic disorders. In a filing with the Bombay Stock Exchange (BSE), Dr. Reddy’s said both partners would cooperate in developing drugs and clinically testing them. Once they got a green signal from the authorities, they may licence it out to a larger pharmaceutical company for further development, said the communiqu
Related Stories
- Lupin buys anti-cholesterol drug rights for $39 mn - Sep 29, 2009
- Dr Reddy's ties up with GlaxoSmithKline - Jun 15, 2009
- TAKE Solutions makes inroad in the APAC region - Jun 03, 2009
- Indian ADRs surge on Wall Street after rally at home - May 19, 2009
- US drug officials raid Sun Pharma's facilities - Jun 26, 2009
- Indian markets end week on a high (Roundup) - Jun 26, 2009
- Glenmark launches skin drugs in the US - Mar 17, 2008
- BSE de-lists Satyam, Sun Pharma replaces scrip on Sensex (Lead) - Jan 08, 2009
- Dr Reddy's claims Satyam land purchase was legal - Jan 28, 2009
- Ranbaxy gets USFDAs permission to manufacture cardiovascular drugs - Mar 09, 2009
Categories
- Business
- - 7tm pharma
- - authorities
- - bombay stock exchange
- - bse
- - denmark
- - dr reddy
- - drug discovery
- - drugs
- - further development
- - g protein coupled receptor
- - India
- - inks
- - medicines
- - metabolic disorders
- - mumbai
- - pact
- - pharmaceutical companies
- - pharmaceutical company
- - protein coupled receptor
- - research and development
Posted in Business, |
